Brian Crawford
About Brian Crawford
Brian Crawford is the Senior Director of Corporate Communications at Sonoma Biotherapeutics, where he has worked since 2023. He has extensive experience in communications and clinical operations, having held various roles at notable companies including Genentech and Astellas Gene Therapies.
Current Role at Sonoma BioTherapeutics
Brian Crawford currently serves as the Senior Director of Corporate Communications at Sonoma BioTherapeutics. He has held this position since 2023. In this role, he leads global meetings and employee all-hands sessions, which enhance internal communications. His responsibilities include optimizing information flow between senior leaders, employees, and the public.
Previous Experience at Sonoma BioTherapeutics
Prior to his current role, Brian Crawford worked at Sonoma BioTherapeutics as the Director of Corporate Communications from 2022 to 2023. During his tenure, he contributed to the development and implementation of communication strategies that supported the company's objectives.
Experience at Astellas Gene Therapies
Brian Crawford served as the Director of Astellas Gene Therapy Communications at Astellas Gene Therapies from 2021 to 2022. His role involved managing communications related to gene therapy initiatives within the organization, contributing to the company's outreach and engagement efforts.
Career at Genentech
Brian Crawford has extensive experience at Genentech, where he held multiple positions over several years. His roles included Senior Director of Communications for Global Product Development, Principal Communications Partner for Global Product Development, and Principal Business and Communications Manager for Pre-Approval Access and Bioethics. His work focused on enhancing communication strategies and supporting clinical operations.
Education and Expertise
Brian Crawford holds a Bachelor of Science degree in Psychobiology from UCLA and a Master of Fine Arts in Writing from the University of San Francisco. He is recognized as an award-winning writer, known for simplifying complex topics for diverse audiences. His expertise includes clinical operations, regulatory policy, and patient access and advocacy.